Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: Effects on regional blood flow

Shock

Volumn 5, Issue 5, 1996, Pages 362-370

  Booke, Michael ^a   Hinder, Frank ^a   McGuire, Roy ^a   Traber, Lillian D ^a   Traber, Daniel L ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NORADRENALIN; VASOCONSTRICTOR AGENT;

ANIMAL; ARTICLE; BLOOD FLOW; DRUG ANTAGONISM; DRUG EFFECT; KIDNEY; PANCREAS; PATHOPHYSIOLOGY; PSEUDOMONAS AERUGINOSA; SEPSIS; SHEEP; VASCULARIZATION;

ANIMALS; ENZYME INHIBITORS; KIDNEY; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; PANCREAS; PSEUDOMONAS AERUGINOSA; REGIONAL BLOOD FLOW; SEPSIS; SHEEP; VASOCONSTRICTOR AGENTS;

EID: 0030133340     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199605000-00009     Document Type: Article

References (42)

1. Increase in National Hospital Discharge Survey rates for septicemia-United States: 1979-1987. MMWR Morb Mortal Wkly Rep 39:31-34, 1990.
2. Barriere SL, Lowry SF: An overview of mortality risk prediction in sepsis. Crit Care Med 23:376-393, 1995.
3. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012, 1993.
4. Nicolson AG, Haites NE, McKay NG, Wilson HM, MacLeod AM, Benjamin N: Induction of nitric oxide synthase in human mesangial cells. Biochem Biophys Res Commun 193:1269-1274, 1993.
5. Pastor C, Teisseire B, Vicaut E, Payen D: Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 22:465-469, 1994.
6. G-methyl-L-arginine are abolished in a canine shock model using high-dose endotoxin. Res Commun Chem Pathol Pharmacol 78:57-68, 1992.
7. Booke M, Meyer J, Lingnau W, Hinder F, Traber LD, Traber DL: Use of nitric oxide inhibitors in animal models of sepsis. New Horizons 3:123-138, 1995.
8. Wolf YG, Cotev S, Perel A, Manny J: Dependence of oxygen consumption on cardiac output in sepsis. Crit Care Med 15:198-203, 1987.
9. Shoemaker WC, Appel PL, Kram HB: Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med 16:1117-1120, 1988.
10. G-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Crit Care Med 22:1835-1840, 1994.
11. Hersch M, Gnidec AA, Bersten AD, Troster M, Rutledge FS, Sibbald WJ: Histologic and ultrastructural changes in nonpulmonary organs during early hyperdynamic sepsis. Surgery 107:397-410, 1991.
12. Koike K, Moore EE, Moore FA, Read RA, Carl VS, Banerjee A: Gut ischemia/reperfusion produces lung injury independent of endotoxin. Crit Care Med 22:1438-1444, 1994.
13. Yoshioka T, Ichikawa I: Glomerular dysfunction induced by polymorphonuclear leukocyte-derived reactive oxygen species. Am J Physiol 257:F53-F59, 1989.
14. Fishbein MC: Reperfusion injury. [Review]. Clin Cardiol 13:213-217, 1990.
15. Nuytinck HK, Offermans XJ, Kubat K, Goris JA: Whole-body inflammation in trauma patients: An autopsy study. [Review]. Arch Surg 123:1519-1524, 1988.
16. Turnage RH, Guice KS, Oldham KT: Pulmonary microvascular injury following intestinal reperfusion. [Review]. New Horizons 2:463-475, 1994.
17. Welbourn CR, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB: Pathophysiology of ischaemia reperfusion injury: Central role of the neutrophil. [Review]. Br J Surg 78:651-655, 1991.
18. Meyer J, Hinder F, Stothert J, Traber LD, Herndon D, Flynn JT, Traber DL: Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J Appl Physiol 76:2785-2793, 1994.
19. Raper RF, Sibbald WJ, Hobson J, Rutledge FS: Effect of PGE1 on altered distribution of regional blood flows in hyperdynamic sepsis. Chest 100:1703-1711, 1991.
20. Fish RE, Lang CH, Spitzer JA: Regional blood flow during continuous low-dose endotoxin infusion. Circ Shock 18:267-275, 1986.
21. Lang CH, Bagby GJ, Ferguson JL, Spitzer JJ: Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol 246:R331-R337, 1984.
22. Thal AP, Robinson RG, Nagamine T, Pruett R, Wegst AV: The critical relationship of intravascular blood volume and vascular capacitance in sepsis. Surg Gynecol Obstet 143:17-22, 1976.
23. Ferguson JL, Spitzer JJ, Miller HI: Effects of endotoxin on regional blood flow in the unanesthetized guinea pig. J Surg Res 25:236-243, 1978.
24. Bersten AD, Hersch M, Cheung H, Rutledge FS, Sibbald WJ: The effect of various sympathomimetics on the regional circulations in hyperdynamic sepsis. Surgery 112:549-561, 1992.
25. Noshima S, Noda H, Herndon DN, Traber LD, Traber DL: Left ventricular performance during continuous endotoxin-induced hyperdynamic endotoxemia in sheep. J Appl Physiol 74:1528-1533, 1993.
26. 2+ in intact cardiac myocytes. Circ Res 74:970-978, 1994.
27. Shah AM: Nitric oxide synthase activities in human myocardium. Lancet 341:448, 1993.
28. Schneider F, Lutun P, Couchot A, Bilbault P, Tempe JD: Plasma cyclic guanosine 3′-5′ monophosphate concentrations and low vascular resistance in human septic shock. Intensive Care Med 19:99-104, 1993.
29. Fish RE, Burns AH, Lang CH, Spitzer JA: Myocardial dysfunction in a nonlethal, nonshock model of chronic endotoxemia. Circ Shock 16:241-252, 1985.
30. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV: Multiple-organ failure syndrome. Arch Surg 121:196-208, 1986.
31. Talbott GA, Sharar SR, Harlan JM, Winn RK: Leukocyte-endothelial interactions and organ injury: The role of adhesion molecules. [Review]. New Horizons 2:545-554, 1994.
32. Lefer AM: Interaction between myocardial depressant factor and vasoaclive mediators with ischemia and shock. Am J Physiol 252:R193-R205, 1987.
33. Suba EA, McKenna TM, Williams TJ: Differential contractile responses of mesenteric and pulmonary artery segments to norepinephrine and phorbol ester in the septic pig. Circ Shock 37:164-168, 1992.
34. Rayner BL, Willcox PA, Pascoe MD: Acute renal failure in community-acquired bacteraemia. Nephron 54:32-35, 1990.
35. Hoffend J, Cavarape A, Endlich K, Steinhausen M: Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation. Am J Physiol 265:F285-F292, 1993.
36. Galat JA, Robinson AV, Rhodes RS: Postischemic renal dysfunction: The limited role of xanthine oxidase-generated oxygen free radicals. J Surg Res 49:488-492, 1990.
37. Lingnau W, McGuire R, Traber LD, Traber DL: Renal function after nitric oxide inhibition in ovine bacterial sepsis. Crit Care Med 22:A122, 1994.
38. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol 261:F1033-F1037, 1991.
39. G-nitroarginine, in dogs. Am J Hypertens 5:484-487, 1992.
40. Garvey EP, Oplinger JA, Tanoury GJ, et al: Potent selective inhibition of human nitric oxide synthases: Inhibition by non-amino acid isothioureas. J Biol Chem 269:2268-2276, 1994.
41. Myers PR, Wright TF, Tanner MA, Adams HR: EDRF and nitric oxide production in cultured endothelial cells: Direct inhibition by E. coli endotoxin. Am J Physiol 262:H710-H718, 1992.
42. Martin CM, Sibbald WJ: Modulation of hemodynamics and organ blood flow by nitric oxide synthase inhibition is not altered in normotensive, septic rats. Am J Respir Crit Care Med 150:1539-1544, 1994.